nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—connective tissue—chronic obstructive pulmonary disease	0.0469	0.319	CbGeAlD
Pentosan Polysulfate—FGF2—bronchus—chronic obstructive pulmonary disease	0.0156	0.106	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—chronic obstructive pulmonary disease	0.0152	0.104	CbGeAlD
Pentosan Polysulfate—FGF1—respiratory system—chronic obstructive pulmonary disease	0.0141	0.0957	CbGeAlD
Pentosan Polysulfate—FGF2—trachea—chronic obstructive pulmonary disease	0.014	0.0951	CbGeAlD
Pentosan Polysulfate—FGF1—connective tissue—chronic obstructive pulmonary disease	0.0124	0.0843	CbGeAlD
Pentosan Polysulfate—FGF1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0113	0.0771	CbGeAlD
Pentosan Polysulfate—FGF2—lung—chronic obstructive pulmonary disease	0.0101	0.0684	CbGeAlD
Pentosan Polysulfate—FGF1—lung—chronic obstructive pulmonary disease	0.00747	0.0508	CbGeAlD
Pentosan Polysulfate—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00492	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00492	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00205	0.00492	CcSEcCtD
Pentosan Polysulfate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00202	0.00484	CcSEcCtD
Pentosan Polysulfate—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00196	0.0047	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00194	0.00467	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00465	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00465	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.00463	CcSEcCtD
Pentosan Polysulfate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00188	0.0045	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00187	0.00448	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00183	0.00438	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.00438	CcSEcCtD
Pentosan Polysulfate—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00179	0.0043	CcSEcCtD
Pentosan Polysulfate—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00179	0.0043	CcSEcCtD
Pentosan Polysulfate—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.0043	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00179	0.00429	CcSEcCtD
Pentosan Polysulfate—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00425	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00423	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00423	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.00417	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00416	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00415	CcSEcCtD
Pentosan Polysulfate—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00415	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00414	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00414	CcSEcCtD
Pentosan Polysulfate—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00408	CcSEcCtD
Pentosan Polysulfate—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00406	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00406	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00406	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00402	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00402	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00401	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00399	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00397	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00164	0.00395	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00393	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00161	0.00388	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00383	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00379	CcSEcCtD
Pentosan Polysulfate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00156	0.00375	CcSEcCtD
Pentosan Polysulfate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00156	0.00375	CcSEcCtD
Pentosan Polysulfate—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00372	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00372	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00361	CcSEcCtD
Pentosan Polysulfate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0015	0.0036	CcSEcCtD
Pentosan Polysulfate—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.0036	CcSEcCtD
Pentosan Polysulfate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00357	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00357	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00356	CcSEcCtD
Pentosan Polysulfate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00356	CcSEcCtD
Pentosan Polysulfate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00148	0.00355	CcSEcCtD
Pentosan Polysulfate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00147	0.00354	CcSEcCtD
Pentosan Polysulfate—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00342	CcSEcCtD
Pentosan Polysulfate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.00336	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.00332	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00328	CcSEcCtD
Pentosan Polysulfate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00328	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00327	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00327	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00325	CcSEcCtD
Pentosan Polysulfate—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00324	CcSEcCtD
Pentosan Polysulfate—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00324	CcSEcCtD
Pentosan Polysulfate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00322	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.0032	CcSEcCtD
Pentosan Polysulfate—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00318	CcSEcCtD
Pentosan Polysulfate—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00318	CcSEcCtD
Pentosan Polysulfate—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00317	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00314	CcSEcCtD
Pentosan Polysulfate—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00312	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00309	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00309	CcSEcCtD
Pentosan Polysulfate—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00306	CcSEcCtD
Pentosan Polysulfate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00305	CcSEcCtD
Pentosan Polysulfate—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.003	CcSEcCtD
Pentosan Polysulfate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.003	CcSEcCtD
Pentosan Polysulfate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.003	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.003	CcSEcCtD
Pentosan Polysulfate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.003	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00125	0.003	CcSEcCtD
Pentosan Polysulfate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00125	0.003	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00299	CcSEcCtD
Pentosan Polysulfate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00296	CcSEcCtD
Pentosan Polysulfate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00296	CcSEcCtD
Pentosan Polysulfate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00294	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00294	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00291	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00121	0.0029	CcSEcCtD
Pentosan Polysulfate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00287	CcSEcCtD
Pentosan Polysulfate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00287	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00287	CcSEcCtD
Pentosan Polysulfate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00286	CcSEcCtD
Pentosan Polysulfate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00286	CcSEcCtD
Pentosan Polysulfate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00283	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00283	CcSEcCtD
Pentosan Polysulfate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00283	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00282	CcSEcCtD
Pentosan Polysulfate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00282	CcSEcCtD
Pentosan Polysulfate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.0028	CcSEcCtD
Pentosan Polysulfate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00117	0.0028	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00278	CcSEcCtD
Pentosan Polysulfate—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00277	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00276	CcSEcCtD
Pentosan Polysulfate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00271	CcSEcCtD
Pentosan Polysulfate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.0027	CcSEcCtD
Pentosan Polysulfate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00267	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00267	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00262	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00262	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00262	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00262	CcSEcCtD
Pentosan Polysulfate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00108	0.0026	CcSEcCtD
Pentosan Polysulfate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.0026	CcSEcCtD
Pentosan Polysulfate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00259	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00258	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00257	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00256	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00256	CcSEcCtD
Pentosan Polysulfate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00255	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00253	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00253	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00253	CcSEcCtD
Pentosan Polysulfate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00252	CcSEcCtD
Pentosan Polysulfate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.0025	CcSEcCtD
Pentosan Polysulfate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00249	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00248	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00247	CcSEcCtD
Pentosan Polysulfate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00246	CcSEcCtD
Pentosan Polysulfate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00246	CcSEcCtD
Pentosan Polysulfate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00246	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00244	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00242	CcSEcCtD
Pentosan Polysulfate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.001	0.0024	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000996	0.00239	CcSEcCtD
Pentosan Polysulfate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000992	0.00238	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000991	0.00238	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000989	0.00237	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000987	0.00237	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000987	0.00237	CcSEcCtD
Pentosan Polysulfate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000986	0.00237	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000983	0.00236	CcSEcCtD
Pentosan Polysulfate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000982	0.00236	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00098	0.00235	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00098	0.00235	CcSEcCtD
Pentosan Polysulfate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000967	0.00232	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000959	0.0023	CcSEcCtD
Pentosan Polysulfate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000952	0.00228	CcSEcCtD
Pentosan Polysulfate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000952	0.00228	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000947	0.00227	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000947	0.00227	CcSEcCtD
Pentosan Polysulfate—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000944	0.00227	CcSEcCtD
Pentosan Polysulfate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000944	0.00226	CcSEcCtD
Pentosan Polysulfate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000936	0.00225	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000935	0.00224	CcSEcCtD
Pentosan Polysulfate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000935	0.00224	CcSEcCtD
Pentosan Polysulfate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000932	0.00224	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00224	CcSEcCtD
Pentosan Polysulfate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00093	0.00223	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000928	0.00223	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000925	0.00222	CcSEcCtD
Pentosan Polysulfate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000909	0.00218	CcSEcCtD
Pentosan Polysulfate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000899	0.00216	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000894	0.00215	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000883	0.00212	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000883	0.00212	CcSEcCtD
Pentosan Polysulfate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000882	0.00212	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000864	0.00207	CcSEcCtD
Pentosan Polysulfate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.00203	CcSEcCtD
Pentosan Polysulfate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000848	0.00203	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000833	0.002	CcSEcCtD
Pentosan Polysulfate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00083	0.00199	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00082	0.00197	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00082	0.00197	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000808	0.00194	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000803	0.00193	CcSEcCtD
Pentosan Polysulfate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0008	0.00192	CcSEcCtD
Pentosan Polysulfate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000792	0.0019	CcSEcCtD
Pentosan Polysulfate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000792	0.0019	CcSEcCtD
Pentosan Polysulfate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000776	0.00186	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00186	CcSEcCtD
Pentosan Polysulfate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000762	0.00183	CcSEcCtD
Pentosan Polysulfate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000762	0.00183	CcSEcCtD
Pentosan Polysulfate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000755	0.00181	CcSEcCtD
Pentosan Polysulfate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000755	0.00181	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000755	0.00181	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000755	0.00181	CcSEcCtD
Pentosan Polysulfate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000754	0.00181	CcSEcCtD
Pentosan Polysulfate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00075	0.0018	CcSEcCtD
Pentosan Polysulfate—Headache—Formoterol—chronic obstructive pulmonary disease	0.00075	0.0018	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00075	0.0018	CcSEcCtD
Pentosan Polysulfate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000748	0.00179	CcSEcCtD
Pentosan Polysulfate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000746	0.00179	CcSEcCtD
Pentosan Polysulfate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00074	0.00178	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00177	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000738	0.00177	CcSEcCtD
Pentosan Polysulfate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000737	0.00177	CcSEcCtD
Pentosan Polysulfate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000735	0.00176	CcSEcCtD
Pentosan Polysulfate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000719	0.00173	CcSEcCtD
Pentosan Polysulfate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000717	0.00172	CcSEcCtD
Pentosan Polysulfate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000713	0.00171	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000713	0.00171	CcSEcCtD
Pentosan Polysulfate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000712	0.00171	CcSEcCtD
Pentosan Polysulfate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000712	0.00171	CcSEcCtD
Pentosan Polysulfate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000709	0.0017	CcSEcCtD
Pentosan Polysulfate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000697	0.00167	CcSEcCtD
Pentosan Polysulfate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000672	0.00161	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000669	0.0016	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000649	0.00156	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000627	0.00151	CcSEcCtD
Pentosan Polysulfate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.00141	CcSEcCtD
Pentosan Polysulfate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000586	0.00141	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000583	0.0014	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000536	0.00129	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000535	0.00128	CcSEcCtD
Pentosan Polysulfate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00128	CcSEcCtD
Pentosan Polysulfate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000531	0.00127	CcSEcCtD
Pentosan Polysulfate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000521	0.00125	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000515	0.00124	CcSEcCtD
Pentosan Polysulfate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000492	0.00118	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000492	0.00118	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00117	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.00115	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000471	0.00113	CcSEcCtD
Pentosan Polysulfate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000468	0.00112	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000456	0.00109	CcSEcCtD
Pentosan Polysulfate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000449	0.00108	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	0.00044	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.00044	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-related events—IL6—chronic obstructive pulmonary disease	0.000437	0.001	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-related events triggered by IGF1R—IL6—chronic obstructive pulmonary disease	0.000433	0.000993	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000433	0.000992	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00043	0.00103	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.00103	CcSEcCtD
Pentosan Polysulfate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000426	0.00102	CcSEcCtD
Pentosan Polysulfate—FGF4—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	0.000425	0.000974	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000423	0.00102	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	0.000423	0.000969	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Insulin receptor signalling cascade—IL6—chronic obstructive pulmonary disease	0.000422	0.000967	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IGF1R signaling cascade—IL6—chronic obstructive pulmonary disease	0.000422	0.000967	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	0.000421	0.000964	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00042	0.000963	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000419	0.00096	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 signaling—IL6—chronic obstructive pulmonary disease	0.000419	0.00096	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000415	0.000996	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000413	0.000946	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-mediated signalling—IL6—chronic obstructive pulmonary disease	0.00041	0.00094	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00041	0.000983	CcSEcCtD
Pentosan Polysulfate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.000982	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.000981	CcSEcCtD
Pentosan Polysulfate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000406	0.000975	CcSEcCtD
Pentosan Polysulfate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000967	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000402	0.000921	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-related events—IL6—chronic obstructive pulmonary disease	0.000399	0.000914	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-related events triggered by IGF1R—IL6—chronic obstructive pulmonary disease	0.000395	0.000906	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	0.000394	0.000903	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	0.000394	0.000903	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—IL6—chronic obstructive pulmonary disease	0.000394	0.000903	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	0.00039	0.000895	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	0.00039	0.000894	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000388	0.000932	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000388	0.000889	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	0.000387	0.000887	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000385	0.000925	CcSEcCtD
Pentosan Polysulfate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000385	0.000925	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	0.000385	0.000883	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IGF1R signaling cascade—IL6—chronic obstructive pulmonary disease	0.000385	0.000882	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Insulin receptor signalling cascade—IL6—chronic obstructive pulmonary disease	0.000385	0.000882	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—TLR2—chronic obstructive pulmonary disease	0.000379	0.000868	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000376	0.000863	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000375	0.000899	CcSEcCtD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.000373	0.000856	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	0.000373	0.000856	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000894	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000373	0.000854	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000367	0.000842	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KL—chronic obstructive pulmonary disease	0.000356	0.000816	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	0.000356	0.000816	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000354	0.000811	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HDAC2—chronic obstructive pulmonary disease	0.000354	0.00081	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000352	0.000806	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	0.000351	0.000804	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	0.000351	0.000804	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	0.000349	0.0008	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	0.000349	0.0008	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	0.000349	0.0008	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000348	0.000798	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	0.000347	0.000796	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000833	CcSEcCtD
Pentosan Polysulfate—FGF1—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	0.000346	0.000793	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	0.000341	0.000781	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	0.00034	0.00078	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.00034	0.00078	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.00034	0.00078	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.00034	0.000779	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000339	0.000776	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000335	0.000768	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000334	0.0008	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—KL—chronic obstructive pulmonary disease	0.000329	0.000753	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	0.000325	0.000746	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	0.000325	0.000746	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	0.000325	0.000746	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000774	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	0.000322	0.000739	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000321	0.000735	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	0.00032	0.000734	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	0.00032	0.000733	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	0.00032	0.000732	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	0.000318	0.00073	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	0.000318	0.000729	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	0.000317	0.000726	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	0.000315	0.000723	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000312	0.000716	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000312	0.000748	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	0.000311	0.000712	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.00031	0.000711	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000306	0.000702	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—EGFR—chronic obstructive pulmonary disease	0.000301	0.00069	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.0003	0.000688	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	0.0003	0.000687	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000719	CcSEcCtD
Pentosan Polysulfate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000713	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000713	CcSEcCtD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	0.000297	0.00068	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	0.000297	0.00068	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	0.000297	0.00068	CbGpPWpGaD
Pentosan Polysulfate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000709	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	0.000294	0.000674	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000292	0.000668	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	0.000291	0.000668	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000291	0.000667	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	0.00029	0.000665	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	0.000288	0.00066	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD8A—chronic obstructive pulmonary disease	0.000287	0.000658	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	0.000287	0.000658	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000285	0.000653	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	0.000282	0.000647	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000672	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000279	0.00064	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000279	0.00064	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—EGFR—chronic obstructive pulmonary disease	0.000275	0.000629	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000274	0.000628	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	0.000273	0.000627	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	0.00027	0.000618	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000269	0.000616	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	0.000268	0.000615	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—IL6—chronic obstructive pulmonary disease	0.000268	0.000615	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	0.000267	0.000612	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000267	0.000612	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000267	0.000611	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000267	0.000611	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000266	0.00061	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000266	0.000609	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—IL6—chronic obstructive pulmonary disease	0.000266	0.000609	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000265	0.000608	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	0.000263	0.000602	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	0.000262	0.0006	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	0.000258	0.00059	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000257	0.000589	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000255	0.000584	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000255	0.000584	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	0.00025	0.000573	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	0.00025	0.000573	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—IL6—chronic obstructive pulmonary disease	0.00025	0.000573	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	0.000248	0.000568	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000248	0.000568	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERBB3—chronic obstructive pulmonary disease	0.000246	0.000565	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	0.000246	0.000564	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	0.000246	0.000563	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	0.000245	0.000561	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	0.000245	0.00056	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CRP—chronic obstructive pulmonary disease	0.000244	0.000559	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	0.000244	0.000558	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000243	0.000557	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000242	0.000556	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—IL6—chronic obstructive pulmonary disease	0.000242	0.000555	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TLR2—chronic obstructive pulmonary disease	0.00024	0.000551	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000234	0.000537	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—TLR4—chronic obstructive pulmonary disease	0.000234	0.000536	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000232	0.000533	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00023	0.000528	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—IL6—chronic obstructive pulmonary disease	0.000228	0.000523	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	0.000228	0.000523	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	0.000228	0.000523	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KL—chronic obstructive pulmonary disease	0.000226	0.000518	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	0.000226	0.000518	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HDAC2—chronic obstructive pulmonary disease	0.000224	0.000514	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	0.000224	0.000513	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	0.000223	0.000511	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	0.000222	0.000508	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	0.000221	0.000508	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.00022	0.000504	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TLR2—chronic obstructive pulmonary disease	0.000219	0.000502	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000215	0.000493	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000212	0.000487	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KL—chronic obstructive pulmonary disease	0.000209	0.000478	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KL—chronic obstructive pulmonary disease	0.000206	0.000472	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOS2—chronic obstructive pulmonary disease	0.000205	0.000471	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HDAC2—chronic obstructive pulmonary disease	0.000205	0.000469	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	0.000202	0.000463	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	0.000202	0.000463	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000199	0.000456	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000196	0.000449	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000191	0.000438	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KL—chronic obstructive pulmonary disease	0.00019	0.000436	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00019	0.000435	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD8A—chronic obstructive pulmonary disease	0.000182	0.000418	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000173	0.000397	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000173	0.000395	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—IL6—chronic obstructive pulmonary disease	0.00017	0.00039	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000169	0.000388	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD8A—chronic obstructive pulmonary disease	0.000166	0.000381	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000166	0.000381	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOS3—chronic obstructive pulmonary disease	0.000165	0.000379	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000162	0.00037	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000157	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB3—chronic obstructive pulmonary disease	0.000156	0.000358	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—IL6—chronic obstructive pulmonary disease	0.000155	0.000356	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CRP—chronic obstructive pulmonary disease	0.000155	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000154	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000154	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—IL6—chronic obstructive pulmonary disease	0.000153	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL1B—chronic obstructive pulmonary disease	0.000152	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TLR4—chronic obstructive pulmonary disease	0.000148	0.00034	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000146	0.000335	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000145	0.000332	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000143	0.000328	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB3—chronic obstructive pulmonary disease	0.000143	0.000327	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CRP—chronic obstructive pulmonary disease	0.000141	0.000324	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TLR4—chronic obstructive pulmonary disease	0.000135	0.00031	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000135	0.000309	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000133	0.000305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000133	0.000305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000131	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS2—chronic obstructive pulmonary disease	0.00013	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000126	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000124	0.000285	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000123	0.000282	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000121	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000121	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00012	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS2—chronic obstructive pulmonary disease	0.000119	0.000273	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—chronic obstructive pulmonary disease	0.000116	0.000266	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000116	0.000265	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000115	0.000264	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000111	0.000254	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00011	0.000252	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.00011	0.000252	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.00011	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—chronic obstructive pulmonary disease	0.000109	0.00025	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—chronic obstructive pulmonary disease	0.000107	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000105	0.000242	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—chronic obstructive pulmonary disease	0.000105	0.00024	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000103	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.0001	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SERPINE1—chronic obstructive pulmonary disease	0.0001	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.99e-05	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.8e-05	0.000225	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.71e-05	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—chronic obstructive pulmonary disease	9.66e-05	0.000221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.61e-05	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—chronic obstructive pulmonary disease	9.56e-05	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.28e-05	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.94e-05	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—chronic obstructive pulmonary disease	8.91e-05	0.000204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—chronic obstructive pulmonary disease	8.86e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—chronic obstructive pulmonary disease	8.81e-05	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.33e-05	0.000191	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—chronic obstructive pulmonary disease	8.23e-05	0.000189	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.69e-05	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.65e-05	0.000175	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.5e-05	0.000172	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—chronic obstructive pulmonary disease	7.36e-05	0.000169	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.34e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.01e-05	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—chronic obstructive pulmonary disease	6.93e-05	0.000159	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—chronic obstructive pulmonary disease	6.8e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—chronic obstructive pulmonary disease	6.71e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.69e-05	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.51e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—chronic obstructive pulmonary disease	6.32e-05	0.000145	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.3e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—chronic obstructive pulmonary disease	6.2e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.94e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.89e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.76e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—chronic obstructive pulmonary disease	5.66e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.37e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.29e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—chronic obstructive pulmonary disease	5.22e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—chronic obstructive pulmonary disease	5.16e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.85e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.82e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—chronic obstructive pulmonary disease	4.76e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.76e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.43e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.34e-05	9.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4e-05	9.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.66e-05	8.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.64e-05	8.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.34e-05	7.65e-05	CbGpPWpGaD
